New Drug Discovery Today webinar: Register Now
In Association with: 
Aequorin bioluminescence assays – a paradigm shift?
Date: Thursday 24th September 2009
Time: 6pm BST, 1pm EST
Duration: 60 minutes
Registration is free.
Reserve your place now.
With over 40% of drug discovery focused on GPCR targets, the need for reliable, proven and versatile assays and instrumentation to understand these complex signaling mechanisms has never been greater. Aequorin-based Ca2+ assays represent a new paradigm in drug discovery research for cell-based assays for Ca2+-coupled GPCRs and ion channels.
This educational webinar is free, lively and highly interactive. Come and hear more about this powerful assay platform and the tools and techniques critical to leveraging its use in assay development, small scale and high throughput screening as well as follow up screens. Simply follow this link to register.
This informative session, moderated by Dr. Stephen Rees, the Director of the Screening and Compound Profiling Department at GlaxoSmithKline, will include presentations by the following speakers:
Dr. Jim Keefer, Senior Scientist, Cell Biology/Pharmacology at Caliper Life Sciences Co and Dr. Parita Shah, GlaxoSmithKline.
Following the presentations, there will be a round table discussion with the moderator, to better understand the value of the Aequorin and how it fits alongside other technologies used in drug discovery.
Now you can keep track of the latest trends
and developments in your speciality with ScienceDirect's
TOP25. The TOP25 is a free service
which provides top 25 lists of most read articles
- counted by article downloads on ScienceDirect.
Discover the Top 25 articles per title:
Drug
Discovery Today
Drug
Discovery Today: Disease Mechanisms
Drug
Discovery Today: Disease Models
Drug
Discovery Today: Therapeutic Strategies
Drug
Discovery Today: Technologies |
